Acta Med. 2020, 63: 150-158

Corneal Graft Success Rates in HSV Keratitis: A Systematic Review

Konstantinos SkarentzosID, Eleftherios ChatzimichaelID, Eirini-Kanella PanagiotopoulouID, Sergios TaliantzisID, Aristeidis KonstantinidisID, Georgios LabirisID

Department of Ophthalmology, University Hospital of Alexandroupolis, Dragana, Alexandroupolis, Greece

Received July 15, 2020
Accepted October 2, 2020


1. Gaynor BD, Margolis TP, Cunningham ET, Jr. Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin 2000; 40(2): 85–109. <>
2. Valerio GS, Lin CC. Ocular manifestations of herpes simplex virus. Curr Opin Ophthalmol 2019; 30(6): 525–31. <>
3. Weiner G. Demystifying the ocular herpes simplex virus. American Academy of Ophthalmology. (Accessed July 13 2020, at:
4. Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol 2017; 11: 185–91. <> <PubMed>
5. Group HEDS. Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group. Arch Ophthalmol 2000; 118(12): 1617–25.
6. Asbell PA. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy. Trans Am Ophthalmol Soc 2000; 98: 285–303.
7. Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 2010; 128(9): 1178–83. <> <PubMed>
8. Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 2016; 44(9): 824–37. <>
9. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989; 107(8): 1155–9. <>
10. Shimazaki J, Shimmura S, Ishioka M, Tsubota K. Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol 2002; 134(2): 159–65. <>
11. Sarnicola V, Toro P, Sarnicola C, Sarnicola E, Ruggiero A. Long-term graft survival in deep anterior lamellar keratoplasty. Cornea 2012; 31(6): 621–6. <>
12. Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V. Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis Poorly Responsive to Medical Treatment. Cornea 2016; 35(1): 1–5. <>
13. Epstein RJ, Seedor JA, Dreizen NG et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. Ophthalmology 1987; 94(8): 935–44. <>
14. Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology 1998; 105(10): 1855–65. <>
15. Halberstadt M, Machens M, Gahlenbek KA, Bohnke M, Garweg JG. The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin. Br J Ophthalmol 2002; 86(6): 646–52. <> <PubMed>
16. Reinhart WJ, Musch DC, Jacobs DS, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology. Ophthalmology 2011; 118(1): 209–18. <>
17. Gundersen T. Conjunctival flaps in the treatment of corneal disease with reference to a new technique of application. AMA Arch Ophthalmol 1958; 60(5): 880–8. <>
18. Foster CS, Barney NP. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 1992; 80(4): 363–9. <>
19. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 2009; 3(3): e123–30.
20. Effective Public Health Practice Project. Quality assessment tool for quantitative studies. (Accessed July 13 2020, at:
21. Sarnicola V, Toro P. Deep anterior lamellar keratoplasty in herpes simplex corneal opacities. Cornea 2010; 29(1): 60–4. <>
22. Li S, Li M, Gu L, et al. Risk factors influencing survival of acellular porcine corneal stroma in infectious keratitis: a prospective clinical study. J Transl Med 2019; 17(1): 434. <> <PubMed>
23. Shimizu E, Yamaguchi T, Tomida D, et al. Corneal Higher-order Aberrations and Visual Improvement Following Corneal Transplantation in Treating Herpes Simplex Keratitis. Am J Ophthalmol 2017; 184: 1–10. <>
24. Wu SQ, Zhou P, Zhang B, Qiu WY, Yao YF. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis. Am J Ophthalmol 2012; 153(2): 291-9.e292. <>
25. Zheng J, Huang X, Zhang Y, et al. Short-term results of acellular porcine corneal stroma keratoplasty for herpes simplex keratitis. Xenotransplantation 2019; 26(4): e12509. <>
26. Liu X, Zhou Q, Huang X, Liu Z, Bi Y. Clinical evaluation of deep anterior lamellar keratoplasty using glycerol-cryopreserved corneal tissues for refractory herpetic stromal keratitis: An observational study. Medicine (Baltimore) 2016; 95(39): e4892. <> <PubMed>
27. Lyall DA, Tarafdar S, Gilhooly MJ, Roberts F, Ramaesh K. Long term visual outcomes, graft survival and complications of deep anterior lamellar keratoplasty in patients with herpes simplex related corneal scarring. Br J Ophthalmol 2012; 96(9): 1200–3. <>
28. Ren Y, Wang H, Zheng Q, et al. Long-Term Outcomes of Deep Anterior Lamellar Keratoplasty Treating Posterior Stroma-Implicated Herpetic Corneal Opacities. Cornea 2016; 35(3): 299–304. <>
29. Wang J, Zhao G, Xie L, Chen M, Zhao J. Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol 2012; 250(8): 1187–94. <>
30. Altay Y, Tamer S, Kaya AS, Balta O, Burcu A, Ornek F. The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis. Arq Bras Oftalmol 2017; 80(1): 41–5. <>
31. Li J, Ma H, Zhao Z, et al. Deep anterior lamellar keratoplasty using precut anterior lamellar cap for herpes simplex keratitis: a long-term follow-up study. Br J Ophthalmol 2014; 98(4): 448–53. <>
32. Li J, Yu L, Deng Z, et al. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in highrisk corneas. Am J Ophthalmol 2011; 152(5): 762-70.e763. <>
33. Anwar M, Teichmann KD. Big-bubble technique to bare Descemet’s membrane in anterior lamellar keratoplasty. J Cataract Refract Surg 2002; 28(3): 398–403. <>
34. Shimmura S, Shimazaki J, Tsubota K. Therapeutic deep lamellar keratoplasty for cornea perforation. Am J Ophthalmol 2003; 135(6): 896–7. <>
35. King JH, Jr., Mc TJ, Meryman HT. Preservation of corneas for lamellar keratoplasty: a simple method of chemical glycerine-dehydration. Trans Am Ophthalmol Soc 1961; 59: 194–201.
36. Heindl LM, Riss S, Bachmann BO, Laaser K, Kruse FE, Cursiefen C. Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology 2011; 118(2): 294–301. <>
37. Heindl LM, Riss S, Laaser K, Bachmann BO, Kruse FE, Cursiefen C. Split cornea transplantation for 2 recipients – review of the first 100 consecutive patients. Am J Ophthalmol 2011; 152(4): 523-32. e522. <>
38. Shi WY, Xie LX. [Focus on the clinical application of the first artificial bioengineered cornea in China]. Zhonghua Yan Ke Za Zhi 2016; 52(3): 161–3.
39. Zhang MC, Liu X, Jin Y, Jiang DL, Wei XS, Xie HT. Lamellar keratoplasty treatment of fungal corneal ulcers with acellular porcine corneal stroma. Am J Transplant 2015; 15(4): 1068–75. <>
40. Rose ML. Role of endothelial cells in allograft rejection. Vasc Med 1997; 2(2): 105–14. <>
41. Fan S, Stojanovic D, Malvankar-Mehta MS, Hutnik C. Treatment of herpes zoster ophthalmicus: a systematic review and Canadian cost-comparison. Can J Ophthalmol 2018; 53(2): 117–23. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)